Propanc Biopharma, Inc. (PPCB): Total Liabilities

Annual figures by period end, from SEC filings.

$3.38M
As of 2026-06-30
$3.26M
As of 2026-09-30
+2.1%
3-year compound annual growth
+1.9%
5-year compound annual growth
$5.73M2011-06-30: $306.8K2012-06-30: $584.2K2019-06-30: $4.40M2020-06-30: $3.74M2021-06-30: $3.08M2022-06-30: $3.11M2023-06-30: $3.18M2024-06-30: $3.85M2025-06-30: $5.73M2026-06-30: $3.38M$3.38M
2011-06-30 Total Liabilities (USD) 2026-06-30
Period endedTotal LiabilitiesChange YoYSource filing
2026-06-30$3.38M-41.0%2026-09-25, Balance as of period end
2025-06-30$5.73M+48.7%2026-09-25, Balance as of period end
2024-06-30$3.85M+21.2%2025-09-29, Balance as of period end
2023-06-30$3.18M+2.3%2024-09-30, Balance as of period end
2022-06-30$3.11M+0.8%2023-09-28, Balance as of period end
2021-06-30$3.08M-17.6%2022-09-28, Balance as of period end
2020-06-30$3.74M-15.1%2021-09-28, Balance as of period end
2019-06-30$4.40Mn/a2020-10-01, Balance as of period end
No annual figure between 2012-06-30 and 2019-06-30.
2012-06-30$584.2K+90.4%2012-10-15, Balance as of period end
2011-06-30$306.8Kn/a2012-10-15, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Propanc Biopharma, Inc. (PPCB)2026-06-30$3.38M-41.0%
Nomad Power Solutions, Inc. (NMAD)2025-12-31$1.77M+456.8%
PMGC Holdings Inc. (ELAB)2025-12-31$5.03M+115.6%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$28.89M+7.5%
Imunon, Inc. (IMNN)2025-12-31$5.23M-4.5%
Turn Therapeutics Inc. (TTRX)2025-12-31$7.48M+235.8%
CalciMedica, Inc. (CALC)2025-12-31$20.23M+275.8%
PRF Technologies Ltd. (PRFX)2025-12-31$2.71M+0.3%
Chemomab Therapeutics Ltd. (CMMB)2025-12-31$1.48M-56.9%

Compare PPCB, NMAD, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗